Birgit M. Schoeberl - Net Worth and Insider Trading
Birgit M. Schoeberl Net Worth
The estimated net worth of Birgit M. Schoeberl is at least $99,344 dollars as of 2024-11-10. Birgit M. Schoeberl is the Head of Discovery of Merrimack Pharmaceuticals Inc and owns about 6,566 shares of Merrimack Pharmaceuticals Inc (MACK) stock worth over $99,344. Details can be seen in Birgit M. Schoeberl's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Birgit M. Schoeberl has not made any transactions after 2016-07-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Birgit M. Schoeberl
Birgit M. Schoeberl Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Birgit M. Schoeberl owns 1 companies in total, including Merrimack Pharmaceuticals Inc (MACK) .
Click here to see the complete history of Birgit M. Schoeberl’s form 4 insider trades.
Insider Ownership Summary of Birgit M. Schoeberl
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MACK | Merrimack Pharmaceuticals Inc | 2016-07-25 | Head of Discovery |
Birgit M. Schoeberl Latest Holdings Summary
Birgit M. Schoeberl currently owns a total of 1 stock. Birgit M. Schoeberl owns 6,566 shares of Merrimack Pharmaceuticals Inc (MACK) as of July 25, 2016, with a value of $99,344.
Latest Holdings of Birgit M. Schoeberl
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MACK | Merrimack Pharmaceuticals Inc | 2016-07-25 | 6,566 | 15.13 | 99,344 |
Holding Weightings of Birgit M. Schoeberl
Birgit M. Schoeberl Form 4 Trading Tracker
According to the SEC Form 4 filings, Birgit M. Schoeberl has made a total of 0 transactions in Merrimack Pharmaceuticals Inc (MACK) over the past 5 years. The most-recent trade in Merrimack Pharmaceuticals Inc is the sale of 5,000 shares on July 25, 2016, which brought Birgit M. Schoeberl around $275,000.
Insider Trading History of Birgit M. Schoeberl
- 1
Birgit M. Schoeberl Trading Performance
Birgit M. Schoeberl Ownership Network
Ownership Network List of Birgit M. Schoeberl
Ownership Network Relation of Birgit M. Schoeberl
Birgit M. Schoeberl Owned Company Details
What does Merrimack Pharmaceuticals Inc do?
Who are the key executives at Merrimack Pharmaceuticals Inc?
Birgit M. Schoeberl is the Head of Discovery of Merrimack Pharmaceuticals Inc. Other key executives at Merrimack Pharmaceuticals Inc include director & other: See Remarks Eric Andersen , director & President Gary L Crocker , and director & other: See Remarks Noah G. Levy .
Merrimack Pharmaceuticals Inc (MACK) Insider Trades Summary
Over the past 18 months, Birgit M. Schoeberl made no insider transaction in Merrimack Pharmaceuticals Inc (MACK). Other recent insider transactions involving Merrimack Pharmaceuticals Inc (MACK) include a net purchase of 446,418 shares made by Eric Andersen , and a net purchase of 4,000 shares made by Gary L Crocker .
In summary, during the past 3 months, insiders sold 0 shares of Merrimack Pharmaceuticals Inc (MACK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Merrimack Pharmaceuticals Inc (MACK) were sold and 450,418 shares were bought by its insiders, resulting in a net purchase of 450,418 shares.
Merrimack Pharmaceuticals Inc (MACK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Merrimack Pharmaceuticals Inc Insider Transactions
Birgit M. Schoeberl Mailing Address
Above is the net worth, insider trading, and ownership report for Birgit M. Schoeberl. You might contact Birgit M. Schoeberl via mailing address: Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
